Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
The high molecular weight, multidomain VAR2CSA protein mediating adhesion of Plasmodium falciparum-infected erythrocytes in the placenta is the leading candidate for a pregnancy malaria vaccine. However, it has been difficult so far to generate strong and consistent adhesion blocking antibody responses against most single-domain VAR2CSA immunogens. Recent advances in expression of the full-length recombinant protein showed it binds with much greater specificity and affinity to chondroitin sulphate A (CSA) than individual VAR2CSA domains. This raises the possibility that a specific CSA binding pocket(s) is formed in the full length antigen and could be an important target for vaccine development. In this study, we compared the immunogenicity of a full-length VAR2CSA recombinant protein containing all six Duffy binding-like (DBL) domains to that of a three-domain construct (DBL4-6) in mice and rabbits. Animals immunized with either immunogen acquired antibodies reacting with several VAR2CSA individual domains by ELISA, but antibody responses against the highly conserved DBL4 domain were weaker in animals immunized with full-length DBL1-6 recombinant protein compared to DBL4-6 recombinant protein. Both immunogens induced cross-reactive antibodies to several heterologous CSA-binding parasite lines expressing different VAR2CSA orthologues. However, antibodies that inhibited adhesion of parasites to CSA were only elicited in rabbits immunized with full-length immunogen and inhibition was restricted to the homologous CSA-binding parasite. These findings demonstrate that partial and full-length VAR2CSA immunogens induce cross-reactive antibodies, but inhibitory antibody responses to full-length immunogen were highly allele-specific and variable between animal species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably antibodies to the full length VAR2CSA inhibited the binding of homologous parasite isolate [23,58] but not heterologous parasites [56,58].”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [58]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108 · cited 1×
“A key feature of PAM is the selective accumulation of Plasmodium falciparum infected erythrocytes (IEs) in the placenta mediated by adhesion to chondroitin sulfate A (CSA) [2].”
BackgroundBaruch, D. I., Pasloske, B. L., Singh, H. B., Bi, X., Ma, X. C., Feldman, M., Taraschi, T. F., & Howard, R. J. (1995) · Cell · doi:10.1016/0092-8674(95)90054-3 · Cited by 1,030 · cited 1×
“VAR2CSA belongs to the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family encoded by var genes [8–10] and is the leading PAM vaccine candidate [11–17].”
BackgroundSmith, J. D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R., Newbold, C. I., & Miller, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90056-x · Cited by 1,005 · cited 1×
“VAR2CSA belongs to the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family encoded by var genes [8–10] and is the leading PAM vaccine candidate [11–17].”
BackgroundSelf-citationSalanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702
Maternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659 · cited 1×
“Although women exposed to placental infections acquire antibodies that block adhesion of geographically diverse placental isolates [5], the specific targets of inhibitory antibodies remain unknown and inhibitory epitopes appear to be at least partially strain-dependent [30–32].”
BackgroundScherf, A., Hernandez-Rivas, R., Buffet, P., Bottius, E., Benatar, C., Pouvelle, B., Gysin, J., & Lanzer, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5418 · Cited by 610 · cited 1×
“FCR3csa [46], 7G8csa [23], HB3csa allele A and HB3csa allele B [24], 3D7/NF54csa [31], Pf2004csa [24,27] and Pf2006csa [24,27] were maintained by periodic selection on CSA.”
BackgroundEvidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604 · cited 1×
“Furthermore, VAR2CSA appears to be a major target of the antibody mediated immune response in pregnant women [15,20], and parasites in which var2csa is genetically disrupted largely lose the ability to bind to CSA [12,17] and placental syncytiotrophoblast [21], suggesting it is the primary var gene responsible for pla…”
BackgroundSnounou, G., Zhu, X., Siripoon, N., Jarra, W., Thaithong, S., Brown, K. N., & Viriyakosol, S. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90120-7 · Cited by 546 · cited 1×
“Parasite genotyping was done with MSP1/MSP2 primers [47].”
MethodThe Sick Placenta—The Role of Malaria
Brabin, B. J., Romagosa, C., Abdelgalil, S., Menéndez, C., Verhoeff, F. H., McGready, R., Fletcher, K. A., Owens, S., d'Alessandro, U., Nosten, F., et al. (2004) · Placenta · doi:10.1016/j.placenta.2003.10.019 · Cited by 375 · cited 1×
“Pregnancy associated malaria (PAM) is a major cause of poor mother/child health and increases the risk for maternal anemia, prematurity, low birth weight and infant morbidity and mortality [1].”
BackgroundStaalsoe, T., Shulman, C. E., Bulmer, J. N., Kawuondo, K., Marsh, K., & Hviid, L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15386-x · Cited by 288 · cited 1×
“Women become resistant to pregnancy malaria as they acquire antibodies to antigens expressed on the surface of IEs that inhibit placental adhesion and mediate opsonic phagocytosis [3–7].”
BackgroundA family affair: var genes, PfEMP1 binding, and malaria disease
Kraemer, S. M., & Smith, J. D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.006 · Cited by 287 · cited 1×
“The var gene family encodes cytoadhesion receptors that facilitate IE binding to microvascular endothelium through a variety of different host receptor interactions [18].”
BackgroundSelf-citationBeeson, J. G., Brown, G. V., Molyneux, M. E., Mhango, C., Dzinjalamala, F., & Rogerson, S. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314899 · Cited by 266 · cited 1×
“Women become resistant to pregnancy malaria as they acquire antibodies to antigens expressed on the surface of IEs that inhibit placental adhesion and mediate opsonic phagocytosis [3–7].”
BackgroundSelf-citationDuffy, P. E., & Fried, M. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6620-6623.2003 · Cited by 260 · cited 1×
“Women become resistant to pregnancy malaria as they acquire antibodies to antigens expressed on the surface of IEs that inhibit placental adhesion and mediate opsonic phagocytosis [3–7].”
BackgroundViebig, N. K., Gamain, B., Scheidig, C., Lépolard, C., Przyborski, J., Lanzer, M., Gysin, J., & Scherf, A. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400466 · Cited by 201 · cited 1×
“Furthermore, VAR2CSA appears to be a major target of the antibody mediated immune response in pregnant women [15,20], and parasites in which var2csa is genetically disrupted largely lose the ability to bind to CSA [12,17] and placental syncytiotrophoblast [21], suggesting it is the primary var gene responsible for pla…”
BackgroundSelf-citationHigh Level of var2csa Transcription by Plasmodium falciparum Isolated from the Placenta
Tuikue Ndam, N. G., Salanti, A., Bertin, G., Dahlbäck, M., Fievet, N., Turner, L., Gaye, A., Theander, T., & Deloron, P. (2005) · The Journal of Infectious Diseases · doi:10.1086/430933 · Cited by 179 · cited 2×
“VAR2CSA belongs to the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family encoded by var genes [8–10] and is the leading PAM vaccine candidate [11–17].”
BackgroundSrivastava, A., Gangnard, S., Round, A., Dechavanne, S., Juillerat, A., Raynal, B., Faure, G., Baron, B., Ramboarina, S., Singh, S. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000951107 · Cited by 149 · cited 8×
“In this study, we compared the immunogenicity of a 3D7 VAR2CSA DBL4-6 recombinant protein that binds with low affinity to CSA to a 3D7 VAR2CSA full-length DBL1-6 recombinant protein that binds with nanomolar affinity to CSA [38].”
BackgroundMethodSelf-citationGamain, B., Trimnell, A. R., Scheidig, C., Scherf, A., Miller, L. H., & Smith, J. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/428137 · Cited by 145 · cited 2×
“While initial studies suggested that DBL2, DBL3, and DBL6 bind CSA [13], the specificity of these in vitro interactions has been questioned [36], and it is still unclear whether multiple individual domains independently engage CSA Table 1.”
BackgroundSelf-citationDuffy, M. F., Maier, A. G., Byrne, T. J., Marty, A. J., Elliott, S. R., O’Neill, M. T., Payne, P. D., Rogerson, S. J., Cowman, A. F., Crabb, B. S., et al. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.006 · Cited by 126 · cited 1×
“Furthermore, VAR2CSA appears to be a major target of the antibody mediated immune response in pregnant women [15,20], and parasites in which var2csa is genetically disrupted largely lose the ability to bind to CSA [12,17] and placental syncytiotrophoblast [21], suggesting it is the primary var gene responsible for pla…”
BackgroundKhunrae, P., Dahlbäck, M., Nielsen, M. A., Andersen, G., Ditlev, S. B., Resende, M., Pinto, V. V., Theander, T. G., Higgins, M. K., & Salanti, A. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.040 · Cited by 121 · cited 1×
“casts doubt on the specificity of single DBL domains for CSA. Recently, the whole extracellular region of two different VAR2CSA variants were successfully produced as recombinant proteins and demonstrated to have significantly higher affinity and specificity for CSA than individual domains”
BackgroundBockhorst, J., Lu, F., Janes, J. H., Keebler, J., Gamain, B., Awadalla, P., Su, X.-Z., Samudrala, R., Jojic, N., & Smith, J. D. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.06.007 · Cited by 117 · cited 6×
“VAR2CSA is a large (,350 kDa) and polymorphic protein with six different Duffy binding-like (DBL) domains and two other large interdomain regions [14,22].”
BackgroundSelf-citationUdeinya, I. J., Graves, P. M., Carter, R., Aikawa, M., & Miller, L. H. (1983) · Experimental Parasitology · doi:10.1016/0014-4894(83)90064-4 · Cited by 117 · cited 1×
“that can lead to a reduction in cytoadhesion capacity [51,52] and the 3D7 parasite is known to be poorly cytoadhesive [48].”
BackgroundTranscribed var Genes Associated with Placental Malaria in MalawianWomen
Duffy, M. F., Caragounis, A., Noviyanti, R., Kyriacou, H. M., Choong, E. K., Boysen, K. E., Healer, J., Rowe, J. A., Molyneux, M. E., Brown, G. V., et al. (2006) · Infection and Immunity · doi:10.1128/iai.01978-05 · Cited by 114 · cited 1×
“VAR2CSA belongs to the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family encoded by var genes [8–10] and is the leading PAM vaccine candidate [11–17].”
BackgroundBiggs, B., Kemp, D. J., & Brown, G. V. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2428 · Cited by 114 · cited 1×
“that can lead to a reduction in cytoadhesion capacity [51,52] and the 3D7 parasite is known to be poorly cytoadhesive [48].”
BackgroundBarfod, L., Bernasconi, N. L., Dahlbäck, M., Jarrossay, D., Andersen, P. H., Salanti, A., Ofori, M. F., Turner, L., Resende, M., Nielsen, M. A., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05503.x · Cited by 110 · cited 2×
“Furthermore, VAR2CSA appears to be a major target of the antibody mediated immune response in pregnant women [15,20], and parasites in which var2csa is genetically disrupted largely lose the ability to bind to CSA [12,17] and placental syncytiotrophoblast [21], suggesting it is the primary var gene responsible for pla…”
BackgroundBeeson, J. G., Mann, E. J., Elliott, S. R., Lema, V. M., Tadesse, E., Molyneux, M. E., Brown, G. V., & Rogerson, S. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/381186 · Cited by 109 · cited 2×
“Although women exposed to placental infections acquire antibodies that block adhesion of geographically diverse placental isolates [5], the specific targets of inhibitory antibodies remain unknown and inhibitory epitopes appear to be at least partially strain-dependent [30–32].”
BackgroundSelf-citationThe Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria
Higgins, M. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800086200 · Cited by 100 · cited 1×
“Although CSA-binding properties have been mapped to several VAR2CSA domains using in vitro binding assays [13,33,34], recent published data [35,36] casts doubt on the specificity of single DBL domains for CSA.”
BackgroundSingh, K., Gittis, A. G., Nguyen, P., Gowda, D. C., Miller, L. H., & Garboczi, D. N. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1479 · Cited by 99 · cited 1×
“Although CSA-binding properties have been mapped to several VAR2CSA domains using in vitro binding assays [13,33,34], recent published data [35,36] casts doubt on the specificity of single DBL domains for CSA.”
BackgroundDahlbäck, M., Rask, T. S., Andersen, P. H., Nielsen, M. A., Ndam, N. T., Resende, M., Turner, L., Deloron, P., Hviid, L., Lund, O., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020124 · Cited by 98 · cited 1×
“This ‘‘patchwork’’ of polymorphic epitopes appears to contribute to cross-reactive antibody responses between different CSA-binding parasite lines [23–29], and may facilitate parasite escape from antibody-dependent protective mechanisms, as inhibitory epitopes appear to be at least partially straindependent [30–32].”
BackgroundHIV Impairs Opsonic Phagocytic Clearance of Pregnancy-Associated Malaria Parasites
Keen, J., Serghides, L., Ayi, K., Patel, S. N., Ayisi, J., van Eijk, A., Steketee, R., Udhayakumar, V., & Kain, K. C. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040181 · Cited by 92 · cited 1×
“Women become resistant to pregnancy malaria as they acquire antibodies to antigens expressed on the surface of IEs that inhibit placental adhesion and mediate opsonic phagocytosis [3–7].”
BackgroundNielsen, M. A., Pinto, V. V., Resende, M., Dahlbäck, M., Ditlev, S. B., Theander, T. G., & Salanti, A. (2009) · Infection and Immunity · doi:10.1128/iai.00159-09 · Cited by 92 · cited 4×
“To date, the most potent inhibitory antibodies response has been generated against the highly conserved DBL4 domain [43], but induction has not been consistently achieved against different VAR2CSA DBL4 alleles [42,43].”
BackgroundInfluentialDisruption of Var2csa Gene Impairs Placental Malaria Associated Adhesion Phenotype
Viebig, N. K., Levin, E., Dechavanne, S., Rogerson, S. J., Gysin, J., Smith, J. D., Scherf, A., & Gamain, B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000910 · Cited by 89 · cited 1×
“Furthermore, VAR2CSA appears to be a major target of the antibody mediated immune response in pregnant women [15,20], and parasites in which var2csa is genetically disrupted largely lose the ability to bind to CSA [12,17] and placental syncytiotrophoblast [21], suggesting it is the primary var gene responsible for pla…”
BackgroundSelf-citationStructural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA
Andersen, P., Nielsen, M. A., Resende, M., Rask, T. S., Dahlbäck, M., Theander, T., Lund, O., & Salanti, A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040042 · Cited by 79 · cited 1×
“Furthermore, a low resolution structure of fulllength VAR2CSA protein revealed a much more compact structure than predicted from x-ray crystallographic analysis of individual domains [38], consistent with three dimensional modeling that VAR2CSA surface polymorphism is biased with surprising amounts of invariant surfac…”
BackgroundBeeson, J. G., & Brown, G. V. (2004) · The Journal of Infectious Diseases · doi:10.1086/380975 · Cited by 77 · cited 3×
“that can lead to a reduction in cytoadhesion capacity [51,52] and the 3D7 parasite is known to be poorly cytoadhesive [48].”
BackgroundSelf-citationVigan-Womas, I., Guillotte-Blisnick, M., Scanf, C. L., Igonet, S., Pêtres, S., Juillerat, A., Badaut, C., Nato, F., Schneider, A., Lavergne, A., et al. (2008) · Infection and Immunity · doi:10.1128/iai.00901-08 · Cited by 76 · cited 1×
“A control rabbit plasma generated against the NTSDBL1 var O recombinant protein produced in Baculovirus-infected insect cells [45] was a gift from Odile Mercereau-Puijalon.”
MethodTuikue Ndam, N. G., Fievet, N., Bertin, G., Cottrell, G., Gaye, A., & Deloron, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/425521 · Cited by 67 · cited 2×
“Although women exposed to placental infections acquire antibodies that block adhesion of geographically diverse placental isolates [5], the specific targets of inhibitory antibodies remain unknown and inhibitory epitopes appear to be at least partially strain-dependent [30–32].”
BackgroundBeeson, J. G., Mann, E. J., Byrne, T. J., Caragounis, A., Elliott, S. R., Brown, G. V., & Rogerson, S. J. (2006) · The Journal of Infectious Diseases · doi:10.1086/500145 · Cited by 66 · cited 3×
“were originally selected in different laboratories, we identified a 3D7csa parasite line [31] that was strongly reactive with anti-”
BackgroundResultSelf-citationKhunrae, P., Philip, J. M. D., Bull, D. R., & Higgins, M. K. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.08.027 · Cited by 65 · cited 1×
“Although CSA-binding properties have been mapped to several VAR2CSA domains using in vitro binding assays [13,33,34], recent published data [35,36] casts doubt on the specificity of single DBL domains for CSA.”
BackgroundBarfod, L. K., Nielsen, M. A., Turner, L., Dahlbäck, M., Jensen, A. T. R., Hviid, L., Theander, T. G., & Salanti, A. (2006) · Infection and Immunity · doi:10.1128/iai.01617-05 · Cited by 65 · cited 2×
“Considered with the fact that DBL4 has higher domain conservation [22] and that antiDBL4 antibodies are frequently poorly reactive with the native protein [23,40,53] this suggests the DBL4 domain may be less accessible to antibodies in the native protein, which may contribute to difficulties in consistently generating…”
BackgroundVAR2CSA Expression on the Surface of Placenta‐Derived Plasmodium falciparum–Infected Erythrocytes
Magistrado, P., Salanti, A., Tuikue Ndam, N. G., Mwakalinga, S. B., Resende, M., Dahlbäck, M., Hviid, L., Lusingu, J., Theander, T. G., & Nielsen, M. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/591502 · Cited by 61 · cited 1×
“This ‘‘patchwork’’ of polymorphic epitopes appears to contribute to cross-reactive antibody responses between different CSA-binding parasite lines [23–29], and may facilitate parasite escape from antibody-dependent protective mechanisms, as inhibitory epitopes appear to be at least partially straindependent [30–32].”
BackgroundHommel, M., Elliott, S. R., Soma, V., Kelly, G., Fowkes, F. J. I., Chesson, J. M., Duffy, M. F., Bockhorst, J. P., Avril, M., Müeller, I., et al. (2010) · Infection and Immunity · doi:10.1128/iai.01365-09 · Cited by 60 · cited 2×
“FCR3csa [46], 7G8csa [23], HB3csa allele A and HB3csa allele B [24], 3D7/NF54csa [31], Pf2004csa [24,27] and Pf2006csa [24,27] were maintained by periodic selection on CSA.”
BackgroundSelf-citationAvril, M., Kulasekara, B. R., Gose, S. O., Rowe, C. G., Dahlbäck, M., Duffy, P. E., Fried, M., Salanti, A., Misher, L., Narum, D. L., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01470-07 · Cited by 57 · cited 1×
“. This “patchwork” of polymorphic epitopes appears to contribute to cross-reactive antibody responses between different CSA-binding parasite lines”
BackgroundSelf-citationElliott, S. R., Duffy, M. F., Byrne, T. J., Beeson, J. G., Mann, E. J., Wilson, D. W., Rogerson, S. J., & Brown, G. V. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2848-2856.2005 · Cited by 55 · cited 1×
“insect cells versus 3D7 allele in mammalian cells), the animal species immunized, the adjuvant employed (Freund's complete/incomplete adjuvant versus TiterMax), or simply the size and complexity of full-length VAR2CSA immunogens. Our analysis indicates that multiple different DBL domains are targeted in multi-domain a…”
ResultSelf-citationResende, M., Ditlev, S. B., Nielsen, M. A., Bodevin, S., Bruun, S., Pinto, V. V., Clausen, H., Turner, L., Theander, T. G., Salanti, A., et al. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.02.022 · Cited by 51 · cited 2×
“While initial studies suggested that DBL2, DBL3, and DBL6 bind CSA [13], the specificity of these in vitro interactions has been questioned [36], and it is still unclear whether multiple individual domains independently engage CSA Table 1.”
BackgroundMagistrado, P. A., Minja, D., Doritchamou, J., Tuikue Ndam, N., John, D., Schmiegelow, C., Massougbodji, A., Dahlbäck, M., Ditlev, S. B., Pinto, V. V., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.10.080 · Cited by 49
Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodies
Semblat, J., Raza, A., Kyes, S., & Rowe, J. A. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2005.12.007 · Cited by 44 · cited 1×
“, which could contribute to the poor cross-reactivity. Another possible explanation for the poor recognition of VAR2CSA-DBL6 could come from the capacity of this domain to bind “non-immune” IgM”
BackgroundAvril, M., Cartwright, M. M., Hathaway, M. J., Hommel, M., Elliott, S. R., Williamson, K., Narum, D. L., Duffy, P. E., Fried, M., Beeson, J. G., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00410-09 · Cited by 44
Self-citationFernandez, P., Viebig, N. K., Dechavanne, S., Lépolard, C., Gysin, J., Scherf, A., & Gamain, B. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-170 · Cited by 43
Self-citationIgM, FcμRs, and Malarial Immune Evasion
Czajkowsky, D. M., Salanti, A., Ditlev, S. B., Shao, Z., Ghumra, A., Rowe, J. A., & Pleass, R. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000203 · Cited by 43 · cited 1×
“However, the VAR2CSA-DBL5 has also been reported to bind non-immune IgM [50], and this would not explain why there was good recognition of DBL5 in ELISA.”
BackgroundSeveral domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Salanti, A., Resende, M., Ditlev, S. B., Pinto, V. V., Dahlbäck, M., Andersen, G., Manczak, T., Theander, T. G., & Nielsen, M. A. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-11 · Cited by 42
Beeson, J. G., Andrews, K. T., Boyle, M. J., Duffy, M. F., Choong, E. K., Byrne, T. J., Chesson, J. M., Lawson, A. M., & Chai, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700231200 · Cited by 38 · cited 1×
“Adhesion of IEs to CSA or placental syncytiotrophoblast leads to specific transcriptional upregulation of var2csa [14–16] and native VAR2CSA binds to CSA [19].”
BackgroundSelf-citationNielsen, M. A., Resende, M., Alifrangis, M., Turner, L., Hviid, L., Theander, T. G., & Salanti, A. (2007) · Experimental Parasitology · doi:10.1016/j.exppara.2007.03.002 · Cited by 33 · cited 2×
“Considered with the fact that DBL4 has higher domain conservation [22] and that antiDBL4 antibodies are frequently poorly reactive with the native protein [23,40,53] this suggests the DBL4 domain may be less accessible to antibodies in the native protein, which may contribute to difficulties in consistently generating…”
BackgroundVAR2CSA Domains Expressed in Escherichia coli Induce Cross‐Reactive Antibodies to Native Protein
Oleinikov, A. V., Francis, S. E., Dorfman, J. R., Rossnagle, E., Balcaitis, S., Getz, T., Avril, M., Gose, S., Smith, J. D., Fried, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/529526 · Cited by 31 · cited 1×
“pastoris or HEK293) elicit antibodies that react with CSA-binding isolates [23,24,29,40,41,53], only a few studies have reported inhibitory antibodies [41–43].”
BackgroundSelf-citationOptimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris
Avril, M., Hathaway, M. J., Cartwright, M. M., Gose, S. O., Narum, D. L., & Smith, J. D. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-143 · Cited by 23 · cited 3×
“IT4var18 DBL3 and VAR2CSA DBL recombinant proteins employed in the ELISA assay were produced in Pichia pastoris as previously described [23,44].”
BackgroundMethodSelf-citation
Cited by
Chan, J.-A., Fowkes, F. J. I., & Beeson, J. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1614-3 · Cited by 168
“Furthermore, antibodies generated against full-length [160, 281] and single domains of vAR2CSA [282] by immunisation inhibited adhesion of Ies to CSA, suggesting that vaccine-induced antibodies may have a protective function in vivo.”
BackgroundSelf-citationClausen, T. M., Christoffersen, S., Dahlbäck, M., Langkilde, A. E., Jensen, K. E., Resende, M., Agerbæk, M. Ø., Andersen, D., Berisha, B., Ditlev, S. B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348839 · Cited by 173
“Although recombinant full-length VAR2CSA is very immunogenic the antibodies produced are not crossinhibitory (43).”
BackgroundSirima, S. B., Richert, L., Chêne, A., Konate, A. T., Campion, C., Dechavanne, S., Semblat, J.-P., Benhamouda, N., Bahuaud, M., Loulergue, P., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30739-x · Cited by 124
Self-citationA Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection
Zanghì, G., Vembar, S. S., Baumgarten, S., Ding, S. D., Guizetti, J., Bryant, J. M., Mattei, D., Jensen, A. T. R., Rénia, L., Goh, Y. S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.075 · Cited by 118
“…were blocked with 4% BSA in PBS for 30 min at RT and then incubated with primary antibody for 1 hr at RT; dilutions were 1:1,000 for anti-ATS, 1:1,000 for antiNF54_SpzPfEMP1, 1:200 for anti-var2CSA (Avril et al., 2011), and 1:15,000 for anti-CSP (Okitsu et al., 2007) antibodies in 3% BSA in PBS.”
MethodDesigning a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
Metadata
- Authors
- Avril, M., Hathaway, M. J., Srivastava, A., Dechavanne, S., Hommel, M., Beeson, J. G., Smith, J. D., & Gamain, B.
- Affiliations
- Center for Infectious Disease Research (US)
- Centre National de la Recherche Scientifique (FR)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Corresponding author
- Smith, Joseph D.
- Gamain, Benoît
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-02-07
- Volume
- 6
- Issue
- 2
- Pages
- e16622
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3034725
- OpenAlex
- W2023380419
- Cited by
- 40
- References
- 54
- Citations by year
- 2024: 1 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 7
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Bill and Melinda Gates Foundation
- Sanofi
- European Commission (201222)
- Medical Research Council (FP7/20072013)
- Australian Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Keywords
- VAR2CSA, Plasmodium falciparum, placental adhesions, chondroitin sulfate A, Duffy binding-like domain, cross-reactive antibodies, adhesion inhibition, vaccine candidate
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Protozoan, Antibody Specificity, Antigens, Protozoan, Cells, Cultured, Cross Reactions, Female, Humans, Immunization, Mice, Inbred BALB C, Placenta, Pregnancy, Rabbits, Species Specificity, Pregnancy Complications, Parasitic, Malaria, Falciparum, Malaria Vaccines, Protein Isoforms, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.